title: Safety of albendazole in developing bovine fetuses.
abstract: Albendazole, administered orally at a dose rate of 25 mg/kg of body weight to presumed pregnant cows or heifers on days 21, 31, 41, 51, and 61 of gestation, did not induce toxicosis in embryos or fetuses, and all calves born were structurally normal. Albendazole administration at a rate of 25 mg/kg to cows at 7 and/or 14 days of gestation decreased the apparent conception rate (ie, embryolethality), but did not have a teratogenic effect. Apparent embryolethality was greater in cows administered 25 mg/kg only on day 14, compared with those administered the drug only on day 7. Single dosage of 25 mg/kg given in the final 3 months of gestation did not induce abortion. There were no adverse effects of albendazole at a dosage of 10 or 15 mg/kg on developing embryos or fetuses when administered to presumed pregnant cows at various times in early gestation.
authors.affiliation: Department of Toxicology, SmithKline Beecham Animal Health, West Chester, PA 19380.
authors.forename: V J
authors.initials: VJ
authors.lastname: Theodorides
authors.forename: M C
authors.initials: MC
authors.lastname: Carakostas
authors.forename: J J
authors.initials: JJ
authors.lastname: Colaianne
authors.forename: J F
authors.initials: JF
authors.lastname: Freeman
authors.forename: S W
authors.initials: SW
authors.lastname: Page
mesh_terms: D000284:Administration, Oral; D015766:Albendazole / Q000008:administration & dosage / Q000633:toxicity*; D000818:Animals; D002417:Cattle; D004622:Embryo, Mammalian / Q000187:drug effects; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D005333:Fetus / Q000187:drug effects; D008297:Male; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D013997:Time Factors
chemical_list: D015766:Albendazole